Iruplinalkib

iruplinalkib · Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Iruplinalkib, covering 2024-05-31 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Iruplinalkib in ALK-Positive Advanced Lung Adenocarcinoma After Lorlatinib